Maxime Descy, Corporate Strategy Manager at Curium Pharma

Maxime Descy

Corporate Strategy Manager at Curium Pharma | Brussels, Brussels Region, Belgium

Profile last verified June 2026
Management Consulting Verified Profile Brussels, Brussels Region, Belgium Louvain School of Management
Verified

Personal Email

***@hotmail.com

Personal • High Confidence

Phone Number

(**) *** *** 127

Belgium • Phone

Free account · No credit card · 5 profiles/month

ContactOut Insights AI Generated

Maxime Descy serves as a Corporate Strategy Manager at Curium Pharma, a global leader in nuclear medicine developing radiopharmaceutical products for cancer diagnostics and treatment. He leverages his academic training from the Louvain School of Management to drive strategic initiatives that align with the organization’s clinical and commercial objectives. Operating from Brussels, he integrates management consulting frameworks into the pharmaceutical sector to advance corporate development efforts.

BEST APPROACH TO REACH Maxime Descy

Initiate outreach via personal email with a concise introductory note connecting your capabilities directly to Curium Pharma’s ongoing expansion in oncology and corporate strategy.

Maxime Descy Socials
Maxime Descy Work Experience

Corporate Strategy Manager at Curium Pharma in January 2026 - Present

Case Team Leader at Roland Berger in July 2025 - October 2025

Senior Consultant at Roland Berger in April 2024 - June 2025

See more See less

Consultant at Roland Berger in January 2023 - March 2024

Junior Consultant at Roland Berger in October 2021 - December 2022

Maxime Descy Education

Louvain School of Management, Msc, July 2026

Università Bocconi, July 2026

Université de Namur, BSc, July 2026

See more See less

Université Laval, July 2026

EF Executive Language Institute, July 2026

Maxime Descy Skills
Anglais Leadership Gestion de projet Développement commercial Prise de parole en public Microsoft Excel
About Maxime Descy’s Current Company
Curium Pharma

Curium is the global leader in nuclear medicine, providing life-changing diagnostics and treatment to patients all over the world. We develop, manufacture and distribute world-class radiopharmaceutical products with a renewed focus on cancer, exploring untapped potential for new innovation. We build on remarkable foundations and a legacy of providing reliable and consistent nuclear solutions to tens of thousands of patients every day. Our proven heritage combined with a pioneering approach are the hallmarks from which we provide life-changing diagnostics and therapeutics. Our people are the root of the incredible impact they have. As part of our 2030 vision to become an oncology-focused nuclear medicine leader – both in diagnostics and therapy – we will expand our reach further into Japan and China, continuing to roll out our superior products to a global market. The impact of these investments on patients will be life changing. Our cancer focus is currently in Neuroendocrine Tumors (NETs) and prostate cancer PSMA. We are also working on leveraging the power of AI to improve image quality and accuracy; to identify patterns to help diagnose pathologies and of course to better support physicians. Our Promise We strive to make the impossible possible and to be an organization that will change the face of medicine. Our diverse group of industry experts is unified under one strong and singular focus – to develop, manufacture and supply revolutionary diagnostic and therapeutic radiopharmaceuticals to our customers around the globe with unrivaled reliability and superior service.

Discover more about Curium Pharma
Maxime Descy’s Colleagues
Merve Sariahmet

Merve Sariahmet

Istanbul, Istanbul, Türkiye

Quality Control Manager at Curium Pharma

Quality Control Manager at Curium Pharma
(July 2025 – Present)

Kyriakos Tzafestas

Kyriakos Tzafestas

United Kingdom

M&A | BD&L | Corporate Strategy (Healthcare & Life Sciences)

Director of Business Development at Curium Pharma
(August 2025 – Present)

Chantal Masungi

Chantal Masungi

Brussels Metropolitan Area

Director of Clinical Operations at Curium Pharma/ Prostate Cancer

Director of Clinical Operations at Curium Pharma
(September 2021 – Present)

Guliz Varlimonti

Guliz Varlimonti

Piratello, Emilia-Romagna, Italy

Regulatory Affairs, MSc. Chemical Engineer

Regulatory Affairs Specialist at Curium Pharma
(May 2023 – Present)

Ebrar Nazlim

Ebrar Nazlim

Adana, Türkiye

Chemical Engineer

Junior Quality Control Specialist at Curium Pharma
(December 2025 – Present)

Serkan Oban

Serkan Oban

Kartal, Istanbul, Türkiye

Senior Director - R&D Curium Pharma

Senior Director R&D at Curium Pharma
(July 2025 – Present)

Search similar profiles
Frequently asked questions about Maxime Descy

What is Maxime Descy email address?

Email Maxime Descy at [email protected] and [email protected]. This email is the most updated Maxime Descy's email found in 2026.

How to contact Maxime Descy?

To contact Maxime Descy send an email to [email protected] or [email protected]. (updated on March 11, 2026)

What company does Maxime Descy work for?

Maxime Descy works for Curium Pharma.

What is Maxime Descy's role at Curium Pharma?

Maxime Descy is Corporate Strategy Manager

What industry does Maxime Descy work in?

Maxime Descy works in the Management Consulting industry.

Engage candidates 10x faster

Enjoy unlimited access and discover candidates outside of LinkedIn

Trusted by 1.4M users from 76% of Fortune 500 companies

Microsoft Tenstorrent Merck Rackspace WarnerMedia Societe Generale Yelp Google

The most accurate data ever

CCPA Compliant
GDPR Compliant
150M Personal Emails
200M Work Emails
100M Direct Dials
250M Professional Profiles
40M Company Profiles

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free